Literature DB >> 13295823

Clinical reactions and tolerance to LSD in chronic schizophrenia.

L S CHOLDEN, A KURLAND, C SAVAGE.   

Abstract

Entities:  

Keywords:  ERGOT ALKALOIDS/therapeutic use; SCHIZOPHRENIA/therapy

Mesh：

Substances：

Year:  1955        PMID： 13295823     DOI： 10.1097/00005053-195509000-00001

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN： 0022-3018            Impact factor:   2.254


× No keyword cloud information.
  6 in total

1.  Gross behavioural changes in monkeys following administration of LSD-25, and development of tolerance to LSD-25.

Authors:  S Jonas; J de C Downer
Journal:  Psychopharmacologia       Date:  1964-10-14

2.  Possible involvement of the central dopaminergic system in the antireserpine effect of LSD.

Authors:  M K Menon; W G Clark; D T Masuoka
Journal:  Psychopharmacology (Berl)       Date:  1977-05-09       Impact factor: 4.530

Review 3.  Psychedelics.

Authors:  David E Nichols
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

4.  Mescaline: excitatory effects on acoustic startle are blocked by serotonin2 antagonists.

Authors:  M Davis
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

5.  A Single Dose of LSD Does Not Alter Gene Expression of the Serotonin 2A Receptor Gene (HTR2A) or Early Growth Response Genes (EGR1-3) in Healthy Subjects.

Authors:  Patrick C Dolder; Edna Grünblatt; Felix Müller; Stefan J Borgwardt; Matthias E Liechti
Journal:  Front Pharmacol       Date:  2017-06-28       Impact factor: 5.810

Review 6.  Neuroendocrine Associations Underlying the Persistent Therapeutic Effects of Classic Serotonergic Psychedelics.

Authors:  Emmanuelle A D Schindler; Ryan M Wallace; Jordan A Sloshower; Deepak C D'Souza
Journal:  Front Pharmacol       Date:  2018-03-01       Impact factor: 5.810
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.